Market Overview

Why Samsung Phone Prices Make The '$1,000 iPhone' Unlikely For Apple

Share:
Why Samsung Phone Prices Make The '$1,000 iPhone' Unlikely For Apple

Investors concerned with a potential $1,200 price on the upcoming release of Apple Inc. (NASDAQ: AAPL)'s iPhone 8 may now be able to breathe a sigh of relief, at least according to UBS's Steven Milunovich.

Samsung Electronic (OTC: SSNLF) released its Note 8 smartphone, which costs $950 for the 64GB version, Milunovich said in a research report. This is important because Apple typically prices its own flagship "Plus" iPhone at a slight discount to the Note, so a $900 price tag on the base OLED iPhone 8 follows logically.

tipranks.png

Apple could proceed with two different models, one with a 64GB storage and the other with 256GB storage, the analyst continued. But it is not clear if Apple will upcharge $100 for the higher storage model as it typically does or introduce a higher price target.

Also, Apple will introduce a new LCD model, which could sell in the typical $550 to $650 range. Any additional price cuts would send a clear signal that the company wants the OLED model to be the undisputed flagship phone, Milunovich added.

Should Apple decide to slash the price on its LCD models by $100, its average selling price per iPhone will be just over $700. This would also imply a flat to slightly negative gross margin. If there are no price cuts on the LCD phone and the OLED phone is priced at $900, then the company can earn $11.30 per share in fiscal 2018, representing an upside to the analyst's current $11.15 per share estimate.

Milunovich maintains a Buy rating on Apple's stock with an unchanged $180 price target.

Related Links:

Chart: Why iPhone Average Selling Price Estimates Need To Move Higher

New Info Suggests Rumored Fingerprint Scanner On The New iPhone Is Unlikely

Latest Ratings for AAPL

DateFirmActionFromTo
Nov 2019MaintainsOverweight
Nov 2019MaintainsOverweight
Nov 2019MaintainsOutperform

View More Analyst Ratings for AAPL
View the Latest Analyst Ratings

Posted-In: Analyst Color Long Ideas News Previews Reiteration Events Analyst Ratings Tech Best of Benzinga

 

Related Articles (AAPL + SSNLF)

View Comments and Join the Discussion!

Clementia Pharma May Be A Fit For Investors Looking For Undervalued Biotech Names

Crypto Digest: A Primer And The Top ICO Prospects